These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
450 related items for PubMed ID: 17323194
1. Mitemcinal (GM-611), an orally active motilin receptor agonist, accelerates colonic motility and bowel movement in conscious dogs. Ozaki K, Sudo H, Muramatsu H, Yogo K, Kamei K, Koga H, Itoh Z, Omura S, Takanashi H. Inflammopharmacology; 2007 Feb; 15(1):36-42. PubMed ID: 17323194 [Abstract] [Full Text] [Related]
2. Effects of mitemcinal (GM-611), an acid-resistant nonpeptide motilin receptor agonist, on the gastrointestinal contractile activity in conscious dogs. Ozaki K, Yogo K, Sudo H, Onoma M, Kamei K, Akima M, Koga H, Itoh Z, Omura S, Takanashi H. Pharmacology; 2007 Feb; 79(4):223-35. PubMed ID: 17426410 [Abstract] [Full Text] [Related]
3. Oral mitemcinal (GM-611), an erythromycin-derived prokinetic, accelerates normal and experimentally delayed gastric emptying in conscious dogs. Onoma M, Yogo K, Ozaki K, Kamei K, Akima M, Koga H, Itoh Z, Omura S, Takanashi H. Clin Exp Pharmacol Physiol; 2008 Jan; 35(1):35-42. PubMed ID: 18047625 [Abstract] [Full Text] [Related]
4. Stimulatory action of mitemcinal (GM-611), an acid-resistant non-peptide motilin receptor agonist, on colonic motor activity and defecation: spontaneous and mitemcinal-induced giant migrating contractions during defecation in dogs. Hirabayashi T, Morikawa Y, Matsufuji H, Hoshino K, Hagane K, Ozaki K. Neurogastroenterol Motil; 2009 Oct; 21(10):1085-e91. PubMed ID: 19508333 [Abstract] [Full Text] [Related]
5. An orally active motilin receptor antagonist, MA-2029, inhibits motilin-induced gastrointestinal motility, increase in fundic tone, and diarrhea in conscious dogs without affecting gastric emptying. Ozaki K, Onoma M, Muramatsu H, Sudo H, Yoshida S, Shiokawa R, Yogo K, Kamei K, Cynshi O, Kuromaru O, Peeters TL, Takanashi H. Eur J Pharmacol; 2009 Aug 01; 615(1-3):185-92. PubMed ID: 19445919 [Abstract] [Full Text] [Related]
6. Mitemcinal (GM-611), an orally active motilin agonist, facilitates defecation in rabbits and dogs without causing loose stools. Sudo H, Ozaki K, Muramatsu H, Kamei K, Yogo K, Cynshi O, Koga H, Itoh Z, Omura S, Takanashi H. Neurogastroenterol Motil; 2007 Apr 01; 19(4):318-26. PubMed ID: 17391248 [Abstract] [Full Text] [Related]
7. In vitro pharmacological characterization of mitemcinal (GM-611), the first acid-resistant non-peptide motilin receptor agonist, in smooth muscle of rabbit small intestine. Takanashi H, Yogo K, Ozaki K, Koga H, Itoh Z, Omura S. Pharmacology; 2007 Apr 01; 79(3):137-48. PubMed ID: 17183187 [Abstract] [Full Text] [Related]
8. Mitemcinal (GM-611), an orally active motilin receptor agonist, improves delayed gastric emptying in a canine model of diabetic gastroparesis. Onoma M, Ozaki K, Yogo K, Monnai M, Muramatsu H, Kamei K, Kawabe Y, Hayashi S, Shiga T, Matsuo S, Suzuki M, Itoh Z, Omura S, Takanashi H. Clin Exp Pharmacol Physiol; 2008 Jul 01; 35(7):788-96. PubMed ID: 18346169 [Abstract] [Full Text] [Related]
9. GSK962040: a small molecule, selective motilin receptor agonist, effective as a stimulant of human and rabbit gastrointestinal motility. Sanger GJ, Westaway SM, Barnes AA, Macpherson DT, Muir AI, Jarvie EM, Bolton VN, Cellek S, Näslund E, Hellström PM, Borman RA, Unsworth WP, Matthews KL, Lee K. Neurogastroenterol Motil; 2009 Jun 01; 21(6):657-64, e30-1. PubMed ID: 19374732 [Abstract] [Full Text] [Related]
10. Oral administration of MA-2029, a novel selective and competitive motilin receptor antagonist, inhibits motilin-induced intestinal contractions and visceral pain in rabbits. Sudo H, Yoshida S, Ozaki K, Muramatsu H, Onoma M, Yogo K, Kamei K, Cynshi O, Kuromaru O, Peeters TL, Takanashi H. Eur J Pharmacol; 2008 Mar 10; 581(3):296-305. PubMed ID: 18164286 [Abstract] [Full Text] [Related]
11. [Motilide, motilin-like macrolides]. Omura S, Inatomi N, Itoh Z. Tanpakushitsu Kakusan Koso; 1993 Aug 10; 38(11):1881-90. PubMed ID: 8210432 [No Abstract] [Full Text] [Related]
12. An erythromycin derivative, EM-523, induces motilin-like gastrointestinal motility in dogs. Inatomi N, Satoh H, Maki Y, Hashimoto N, Itoh Z, Omura S. J Pharmacol Exp Ther; 1989 Nov 10; 251(2):707-12. PubMed ID: 2810120 [Abstract] [Full Text] [Related]
13. Effects of motilin and mitemcinal (GM-611) on gastrointestinal contractile activity in rhesus monkeys in vivo and in vitro. Yogo K, Ozaki K, Takanashi H, Koto M, Itoh Z, Omura S. Dig Dis Sci; 2007 Nov 10; 52(11):3112-22. PubMed ID: 17431782 [Abstract] [Full Text] [Related]
14. Erythromycin: a motilin agonist and gastrointestinal prokinetic agent. Weber FH, Richards RD, McCallum RW. Am J Gastroenterol; 1993 Apr 10; 88(4):485-90. PubMed ID: 8470625 [Abstract] [Full Text] [Related]
15. Down-regulation of motilin receptors on rabbit colon myocytes by chronic oral erythromycin. Bologna SD, Hasler WL, Owyang C. J Pharmacol Exp Ther; 1993 Aug 10; 266(2):852-6. PubMed ID: 8355213 [Abstract] [Full Text] [Related]
17. Effect of TZP-201, a novel motilin receptor antagonist, in the colon of the musk shrew (Suncus murinus). Venkova K, Thomas H, Fraser GL, Greenwood-Van Meerveld B. J Pharm Pharmacol; 2009 Mar 10; 61(3):367-73. PubMed ID: 19222910 [Abstract] [Full Text] [Related]
18. EM574, an erythromycin derivative, is a potent motilin receptor agonist in human gastric antrum. Satoh M, Sakai T, Sano I, Fujikura K, Koyama H, Ohshima K, Itoh Z, Omura S. J Pharmacol Exp Ther; 1994 Oct 10; 271(1):574-9. PubMed ID: 7965757 [Abstract] [Full Text] [Related]
19. Nonlinear intestinal pharmacokinetics of mitemcinal, the first acid-resistant non-peptide motilin receptor agonist, in rats. Saitoh R, Miyayama T, Mitsui T, Akiba Y, Higashida A, Takata S, Kawanishi T, Aso Y, Itoh Z, Omura S. Xenobiotica; 2007 Dec 10; 37(12):1421-32. PubMed ID: 17926229 [Abstract] [Full Text] [Related]
20. [Mechanism and clinical application of erythromycin as a gastrointestinal prokinetic agent in children]. Yang Y. Zhongguo Dang Dai Er Ke Za Zhi; 2008 Feb 10; 10(1):102-4. PubMed ID: 18289489 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]